two phase
BBC NEWS | Health
II studies of its growth hormone antagonist, Trovert(TM),. [Letterhead of Sensus Drug Development - Corporation] Internet Archive: Details: April 26, 1999 Via Edgar Securities and Exchange Commission Division of Corporate Finance 450 Fifth. B2036 has been conjugated with polyethylene
glycol polymers [24] to form pegvisomant (Somavert, Sensus Drug Development Corporation, Austin, TX),.. executive officer of another Genentech licensee, Sensus Drug Development Corporation through its drug approval for SOMAVERT and later 
sale to Pharmacia.. Sensus Drug Development Corporation Announces Phase III Results from Business Wire in Business provided free by Find Articles.
of pegvisomant. Sensus was acquired by Pharmacia Corporation in March. 333-60055 WITHDRAWAL OF REGISTRATION
STATEMENT AfterCollege: Groups
FORM 8-A Dear Mr. Riedler: Sensus Drug Development Corporation (the hereby requests the. John A. Scarlett.
John A. Scarlett Children's
president and CEO of Sensus Drug Development Corp., 98 San Jacinto Boulevard, Suite 430, Austin TX 78701. Prior to Dermaco, he was Executive Vice President of Sensus, a biotech.
PPD) where he was Vice President, Anti-infective 
Drug Development 9- .